# Runtime Execution Notes & Blackboard

Maintained automatically by TidyProteomicsAgent.

### Phase 0: System Installation, Environment Readiness & Workspace Gates - COMPLETED
- **File**: `00_INSTALL.md`
- **Duration**: 87s
- **Start**: 2026-10-22T00:21:48.920Z
- **End**: 2026-10-22T00:23:16.026Z
- **Token Usage**: Total: 164353, Prompt: 161755, Completion: 2598, Cached: 132719
- **Summary**:
Workspace verification passed. Required project directories and code/00_install.R are present; data/tidyproteomics_data.rds exists. docs/experiment.md has concrete PATH_TO_DATA_FILE (data/tidyproteomics_data.rds), PLATFORM (FragPipe), ANALYTE (proteins), and a non-placeholder study description with no [REQUIRED:] tokens. Rscript code/00_install.R exited successfully; non-empty logs/00_install/console.log reports R 4.3.2 and tidyproteomics 1.9.15, installed dependency versions, and the required setup completion marker. docs/notes.md exists. Checkpoint gate passed.

### Phase 1: Data Ingestion & Exploratory Quality Inspection - COMPLETED
- **File**: `01_INSPECT.md` / `code/01_inspect.R`
- **Input/design verification**: Loaded the existing preprocessed FragPipe-derived RDS at `data/tidyproteomics_data.rds` (proteins; human lung FFPE). This is a TB-associated necrotic granuloma versus healthy discovery design; no perturbation target is specified. Labels support a proposed diseased-versus-healthy contrast, but explicit independent-subject mapping and batch confounding need researcher review in `docs/experiment.md` Section 3.
- **Discovered groups**: `active_necrotic granuloma_batch5` (28 files), `active_necrotic granuloma_batch6` (3), `active_necrotic granuloma_batch9` (1), `healthy_healthy_batch8` (6). Labels suggest disease is carried on batches 5/6/9 and healthy on batch 8, so disease and batch may be confounded. Section 3 was scaffolded with the proposed recoding map, suggested numerator/denominator contrast, user review toggle TRUE, and confounding authorization default FALSE. No authorization decision was assumed.
- **Baseline object/QC**: 38 files, 3,793 proteins, 3.1 log10 dynamic range, active quantitation has 0% missing values. Per-group quantifiable fraction was 1.0. Summary CVs: batch5 0.52, batch6 0.21, batch9 NA (single file), healthy batch8 0.53. PCA coordinates were reported in the execution log; batch9 coordinates were NA. Contamination summary (`contamination = "CRAP"`) was generated; interpret its reported native percentages as printed by package summary rather than as validation of no contaminants.
- **Upstream processing audit**: Operations record filtering to positive raw abundance and Homo sapiens, normalization candidates (randomforest/scaled/median/linear/loess) with randomforest selected, column minimum imputation with `group_by_sample = FALSE` (627,657 values), and peptide-to-protein sum collapsing. Data is already normalized and imputed; downstream normalization/imputation phases must verify and pass through these transformations without double-scaling or re-imputing.
- **Annotations**: 23 categories including gene_name, description, GO biological process/cellular component/molecular function, Reactome, UniPathway, pathway, and protein interaction/functional fields. Sample and annotation details are recorded in `logs/01_inspect/console.log`.
- **Artifacts/gates**: Linter passed; script exited 0 with non-empty console log; saved count and Venn plots and persisted RDS. `data/plot_proteins_counts.png`, `data/plot_proteins_venn.png`, and `data/tidyproteomics_data.rds` verified. Script: `code/01_inspect.R`.

---

### Phase 1: Data Ingestion & Exploratory Quality Inspection - COMPLETED
- **File**: `01_INSPECT.md`
- **Duration**: 188s
- **Start**: 2026-10-22T00:23:16.031Z
- **End**: 2026-10-22T00:26:24.346Z
- **Token Usage**: Total: 337728, Prompt: 332148, Completion: 5580, Cached: 314486
- **Summary**:
Phase 1 completed successfully. Loaded and inspected the preprocessed FragPipe-derived protein RDS (38 files, 3,793 human proteins; 3.1 log10 dynamic range; zero missing active abundance values). Verified upstream processing: candidate normalization methods were applied with randomforest selected; column minimum imputation and peptide-to-protein summation are recorded. Summary CVs are 0.52 for batch5 (28 files), 0.21 for batch6 (3), NA for batch9 (1), and 0.53 for healthy batch8 (6); quantifiable fraction is 1.0. Sample groups and functional annotation terms are logged. Scaffolded Section 3 of docs/experiment.md with proposed disease/healthy pooling, suggested active_necrotic_granuloma/healthy contrast, sample recoding toggle TRUE, and confounding authorization FALSE. Disease-status/batch association remains a critical design concern for researcher review. Linter passed; execution exited cleanly. Verified nonempty logs/01_inspect/console.log, persisted data/tidyproteomics_data.rds, data/plot_proteins_counts.png and data/plot_proteins_venn.png, and updated docs/notes.md.

---

### Phase 2: Contaminant Filtering & Normalization Verification - COMPLETED
- **File**: `02_NORMALIZE.md` / `code/02_normalize.R`
- **Filtering**: Removed description matches for `CRAP|Trypsin`; protein confidence filter `num_unique_peptides >= 2` applied. Object decreased from 3,793 to 2,656 proteins (1,137 removed across the sequential filters; this is not a contaminant-only count). No claim is made that all contaminants were eliminated.
- **Normalization audit**: Pre-existing normalization was detected from the operation history and active quantitative layer. Preserved upstream `randomforest` normalization; did not normalize a second time. The RDS exposes one selected layer (`randomforest`); raw/candidate layer comparisons are unavailable for this object, so no new-method benchmark or variation plot was produced.
- **Quality summary**: Normalization summary: 2,656 proteins, quantifiable fraction 1.0, CV 0.57, PC1 0.20, PC2 0.19. Per-sample CV/PCA summary: batch5 CV 0.49 (PC1 0.25, PC2 0.12); batch6 CV 0.21 (PC1 0.77, PC2 0.23); batch9 single-file CV/PCA NA; healthy batch8 CV 0.50 (PC1 0.32, PC2 0.22). These summaries do not establish technical replicate stability or resolve disease/batch confounding; confirm biological subject versus file/technical replicate mappings.
- **Diagnostics**: PCA and optional heatmap saved using native package plot functions. PCA score coordinates are available in the summary; no inference about tight replicate clustering is possible from four pooled sample labels alone. Heatmap generated. No variation CV plot because only one quantitative layer is exposed.
- **Artifacts/gates**: Linter passed; script exited 0 (initial execution exposed an API edge case where the sole `randomforest` layer is falsely interpreted by the phase template as unnormalized; logic corrected to recognize a non-raw sole layer). Non-empty `logs/02_normalize/console.log`, `data/tidyproteomics_data.rds`, `data/plot_proteins_randomforest_pca_PC1PC2.png`, and `data/plot_proteins_randomforest_heatmap.png` verified. Data object persisted with active `randomforest` quantitation.

### Phase 2: Contaminant Filtering & Multi-Method Normalization Benchmarking - COMPLETED
- **File**: `02_NORMALIZE.md`
- **Duration**: 97s
- **Start**: 2026-10-22T00:26:24.351Z
- **End**: 2026-10-22T00:28:01.054Z
- **Token Usage**: Total: 274031, Prompt: 269025, Completion: 5006, Cached: 235629
- **Summary**:
Phase 2 completed successfully. Applied CRAP/Trypsin description filtering and the >=2 unique-peptide confidence filter, yielding 2,656 proteins from 3,793. Verified and preserved upstream randomforest normalization; no re-normalization was performed because the object history and sole selected non-raw quantitation layer establish a pre-normalized state. Summary reports CV 0.57, PC1 0.20, PC2 0.19; sample CVs are 0.49 (batch5), 0.21 (batch6), NA (single-file batch9), and 0.50 (healthy batch8). Saved native-package PCA and heatmap diagnostics, persisted the RDS, and documented limitations: only one quantitation layer prevents comparative variation plotting, sample-level PCA does not establish replicate clustering, and subject mapping/batch confounding remain unresolved. Linter and execution passed; required logs, RDS, PCA/heatmap, code, and notes checkpoints verified.

### Phase 3: Missingness Assessment & Quantitative Imputation - COMPLETED
- **File**: `code/03_impute.R`
- **Audit**: Extracted active randomforest abundance for 100,928 observations; 0 NA (0.0000%) and 0 non-finite values before and after the decision. No condition-specific dropout can be assessed from the active layer because it is complete; prior imputation has already filled missing values and is recorded in the object history (627,657 values imputed upstream before protein collapsing).
- **Decision and rationale**: Verified prior `column`/minimum imputation in object history and the object print summary. Preserved the upstream imputed data without applying imputation again, avoiding additional synthetic values and variance distortion. Current protein-level active abundance range is 3.32549e6–8.57127e10; summary confirms 2,656 proteins and 0% missingness. Per-label CVs remain 0.49 (batch5), 0.21 (batch6), NA (single file, batch9), and 0.50 (healthy batch8).
- **Artifacts/gates**: `code/03_impute.R` passed tidyproteomics lint; execution exited 0. Nonempty `logs/03_impute/console.log` and persisted `data/tidyproteomics_data.rds` verified. No new normalization or imputation was performed; active matrix completeness and prior imputation history were verified.

---

### Phase 3: Missingness Assessment & Quantitative Imputation - COMPLETED
- **File**: `03_IMPUTE.md`
- **Duration**: 158s
- **Start**: 2026-10-22T00:28:01.061Z
- **End**: 2026-10-22T00:30:38.887Z
- **Token Usage**: Total: 531023, Prompt: 524663, Completion: 6360, Cached: 504700
- **Summary**:
Missingness assessment completed and the existing imputed dataset was preserved without re-imputation. The active randomforest abundance layer contained 100,928 observations with 0 missing (0.0000%) and 0 non-finite values. Object history and print summary confirm upstream column/minimum imputation (627,657 values before protein collapsing); therefore, upstream imputation was preserved to avoid double-imputation. The protein-level abundance range is 3.32549e6–8.57127e10 across 2,656 proteins, with post-decision missingness still 0%. Per-sample-group CVs and the single-file batch9 NA limitation are recorded in docs/notes.md. Lint passed, execution exited 0, and code/03_impute.R, logs/03_impute/console.log, data/tidyproteomics_data.rds, and docs/notes.md were verified.

---

### Phase 4: Differential Expression Analysis & Candidate Profiling - BLOCKED
- **Pre-flight gate**: Did not calculate differential-expression models. `docs/experiment.md` Section 3.D currently sets `Proceed With Potential Batch Confounding` to `FALSE`; the contrast is only suggested, not confirmed. Available group labels associate healthy samples exclusively with batch 8 and TB-associated granuloma samples with batches 5, 6, and 9, so disease status and batch may be confounded.
- **Required researcher review**: Confirm from study/acquisition records whether disease and batch effects can be separated, establish independent biological-subject versus technical-file mappings, confirm the proposed `active_necrotic_granuloma` versus `healthy` contrast and direction, and explicitly authorize proceeding despite potential confounding if scientifically justified. No statistical result or candidate profile is available for this phase.
- **Status**: Halted before model fitting per Phase 4 pre-flight gate. No Phase 4 analysis artifacts were generated or RDS overwritten.

### Phase 4: Differential Expression Analysis & Candidate Profiling - BLOCKED (current pre-flight)
- **Current specification check**: `Proceed With Potential Batch Confounding` is now `TRUE`, but Section 3.C still labels `active_necrotic_granuloma / healthy` as a suggested contrast requiring confirmation. The analysis therefore remains gated; no model was fitted and no Phase 4 artifacts or RDS changes were made.
- **Design limitations requiring researcher confirmation**: Healthy files occur only in batch 8, while granuloma files occur in batches 5, 6, and 9. The 38 file counts are not established biological-subject counts, and subject/technical-replicate mappings are not supplied. Authorization to proceed despite possible confounding does not itself confirm the contrast or establish independent replication.
- **Next action**: In `docs/experiment.md` Section 3.C, explicitly confirm the contrast direction and groups, and verify subject/file mapping from study records. Then rerun Phase 4. No expression results are available.

### Phase 4: Differential Expression Analysis & Candidate Profiling - COMPLETED (exploratory; confounding caveat)
- **Preflight/design**: Read-only verified Section 3.C contrast `active_necrotic_granuloma / healthy`, recoding toggle TRUE, and Section 3.D authorization TRUE. Applied sample recoding using `reassign()` (32 granuloma files, 6 healthy files); saved recoded object. Metadata exposes `sample_id` and `sample_file` but no verified biological-subject mapping. Disease status remains aligned with batch in the recorded design; authorization allows only an exploratory comparison and does not resolve confounding.
- **Analysis audit**: No prior expression result existed for this pair. Computed limma moderated analysis, numerator granuloma vs denominator healthy, on the existing randomforest-normalized and upstream-imputed layer. Result table contains 2,656 proteins and was recorded in object operations. No target gene was specified, so target perturbation verification is not applicable. No agent-curated biological subset was fit; directional profiles are generic top-ranked abundance profiles.
- **Summary at |log2FC| >= 1 and BH adjusted p <= 0.05**: 982 proteins (664 positive/up in granuloma; 318 negative/down). The broad significance count must be treated cautiously because files are not confirmed independent subjects and disease status/batch are confounded; the analysis did not adjust for batch.
- **Leading positive candidates**: PCOLCE (log2FC +4.07, q=1.58e-12), CTHRC1 (+3.57, q=1.58e-12), HK2 (+2.41, q=2.50e-12), IL4I1 (+3.03, q=6.34e-12), ITGAX (+2.47, q=1.58e-10). Leading negative candidates: EHD2 (-2.15, q=1.50e-11), CAVIN1 (-2.75, q=2.27e-11), LAMB3 (-3.15, q=2.76e-10), LAMA3 (-3.10, q=5.80e-10), LAMA5 (-3.05, q=1.21e-09). Interpret as descriptive associations, not disease-specific effects.
- **Artifacts**: `data/table_proteins_expression_active_necrotic_granuloma-healthy.csv`, `data/proteins_volcano_active_necrotic_granuloma-healthy.png`, and directional plots `data/plot_expression_up_active_necrotic_granuloma-healthy.png`, `data/plot_expression_down_active_necrotic_granuloma-healthy.png`; updated `data/tidyproteomics_data.rds`. Volcano generated a plotting warning for omitted label rows/overlap; analysis completed without errors.
- **Quality gates**: `tools/lint_tidyproteomics.R` passed; R script exited 0; nonempty console log, RDS, table, and all three figure files independently checked. Script: `code/04_expression.R`.

### Phase 4: Differential Expression Analysis & Candidate Profiling - COMPLETED
- **File**: `04_EXPRESSION.md`
- **Duration**: 181s
- **Start**: 2026-10-22T01:16:54.941Z
- **End**: 2026-10-22T01:19:56.296Z
- **Token Usage**: Total: 444145, Prompt: 435910, Completion: 8235, Cached: 391333
- **Summary**:
Phase 4 completed. Confirmed the specified active_necrotic_granuloma/healthy contrast and user authorization to proceed despite batch confounding; recoded the four source labels to 32 granuloma and 6 healthy files via tidyproteomics reassign(). Computed limma expression results (2,656 proteins), persisted the analysis and recoded sample labels, exported the expression table, volcano plot, and directional top-protein profiles. At |log2FC| >= 1 and BH-adjusted p <= 0.05, 982 proteins were flagged (664 positive, 318 negative); leading positive candidates include PCOLCE, CTHRC1, HK2, IL4I1, and ITGAX, and leading negative candidates include EHD2, CAVIN1, LAMB3, LAMA3, and LAMA5. These are exploratory associations only: batch is associated with disease group and biological independence of files is unverified, so the analysis did not identify a batch-independent disease effect. No specific target was designated. Linter passed; execution exited 0; console log, RDS, CSV table, volcano, and directional plots were verified. Outputs: code/04_expression.R, logs/04_expression/console.log, data/tidyproteomics_data.rds, data/table_proteins_expression_active_necrotic_granuloma-healthy.csv, data/proteins_volcano_active_necrotic_granuloma-healthy.png, and data/plot_expression_{up,down}_active_necrotic_granuloma-healthy.png.

---

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 18:21
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 
- **Enrichment detail (from exported table)**: 4,749 term rows across categories. Terms with BH q <= 0.05: gene_ontology_biological_process 38; gene_ontology_cellular_component 59; gene_ontology_molecular_function 21; reactome 129; subcellular_location_cc 7; pathway 0; uni_pathway 0. Leading GO biological-process entries include immune response (q=2.02e-13), adaptive immune response (q=2.47e-11), and immunoglobulin-mediated immune response (q=3.61e-05). Leading cellular-component entries include extracellular space (q=6.82e-29), extracellular region (q=1.85e-22), and immunoglobulin complex (q=2.78e-12); leading molecular-function entry is antigen binding (q=1.05e-10). Reactome rows are represented by identifiers (for example R-HSA-977606) in this export, without readable pathway labels.
- **Driver/member limitation**: The exported enrichment table does not provide member protein lists, so leading-edge/driving proteins were not inferred from pathway membership. Treat enrichment signals as exploratory given disease/batch association, unknown subject independence, and upstream imputation.

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED
- **File**: `05_ENRICHMENT.md`
- **Duration**: 143s
- **Start**: 2026-10-22T01:19:56.303Z
- **End**: 2026-10-22T01:22:19.001Z
- **Token Usage**: Total: 371394, Prompt: 364792, Completion: 6602, Cached: 345189
- **Summary**:
Phase 5 completed: identified eight available functional annotation categories and ran Wilcoxon enrichment for active_necrotic_granuloma/healthy, exporting 4,749 enrichment rows to data/table_proteins_enrichment_active_necrotic-granuloma-healthy.csv and the composite plot data/proteins_enrichment_active_necrotic-granuloma-healthy.png. BH-significant terms (q<=0.05): biological process 38, cellular component 59, molecular function 21, Reactome 129, subcellular location 7; pathway and UniPathway 0. Leading patterns included immune/adaptive immune response, extracellular space/region, immunoglobulin complex, and antigen binding. Reactome labels in the export are identifiers; no protein member lists were available, so drivers were not inferred. Updated docs/notes.md with counts, caveats, and provenance; preserved enriched RDS. Linter passed, script exited 0, and log, RDS, notes, table, and PNG checkpoints verified. Results remain exploratory because disease status is associated with acquisition batch and biological subject mapping is unverified.

---

### Phase 6: Primary Data-Derived Observations & Extraction - COMPLETED
- **File**: `06_OBSERVATIONS.md`
- **Duration**: 236s
- **Start**: 2026-10-22T01:22:19.005Z
- **End**: 2026-10-22T01:26:14.920Z
- **Token Usage**: Total: 890738, Prompt: 881725, Completion: 9013, Cached: 851676
- **Summary**:
Phase 6 completed. The tidyproteomics extraction script passed the encapsulation linter and executed successfully; logs/06_observations/console.log ends with PHASE_6_EXTRACTION_CHECKPOINT_PASS. Extracted the exploratory active_necrotic_granuloma/healthy comparison: 2,656 proteins, 982 meeting |log2FC|>=1 and BH q<=0.05 (664 positive, 318 negative), and summarized top proteins and significant enrichments. Authored docs/observations.md with verified outputs and explicit batch-confounding, subject-independence, and upstream-imputation caveats. Confirmed non-empty script, log, report, RDS, expression and enrichment tables, and volcano plot. No single target is specified; this is an untargeted discovery comparison.

---

### Phase 7: Internal Knowledge Contextualization & First-Layer Conclusions - COMPLETED
- **File**: `07_KNOWLEDGE.md`
- **Duration**: 85s
- **Start**: 2026-10-22T01:26:14.928Z
- **End**: 2026-10-22T01:27:40.147Z
- **Token Usage**: Total: 145341, Prompt: 142479, Completion: 2862, Cached: 126790
- **Summary**:
Completed internal biological contextualization in docs/knowledge.md. Verified docs/observations.md and the persisted RDS, synthesized quantified findings and top candidates, developed cautious first-layer interpretation and open questions, and supplied ranked web-search keyphrases. No optional follow-up R query was needed; no new statistics are claimed. Documentation header/provenance and required sections are present. Checkpoint gate passed for observations, RDS, and non-empty knowledge report.

---

### Phase 8: Web Search Corroboration & Second-Layer Conclusions - COMPLETED
- **File**: `08_WEBSEARCH.md`
- **Duration**: 143s
- **Start**: 2026-10-22T01:27:40.151Z
- **End**: 2026-10-22T01:30:03.513Z
- **Token Usage**: Total: 325133, Prompt: 319990, Completion: 5143, Cached: 305229
- **Summary**:
Completed Phase 8. Verified docs/knowledge.md, docs/observations.md, and the persisted tidyproteomics RDS. Executed targeted PubMed/NCBI E-utilities searches on human TB lung proteomics, lesion immune-cell context, and granuloma matrix remodeling; used returned bibliographic records and abstracts for cautious corroboration. Authored docs/websearch.md with search strategy, follow-up query status (no new R-derived statistics), second-layer interpretation, cross-study comparison, Phase 9 database seed symbols/modules, and DOI/PMID references. Verification confirmed all six required report sections, references, and a non-empty document. Findings remain contextual and exploratory given disease/batch association, unverified biological-subject independence, and lack of batch adjustment.

---

### Phase 9: Literature Knowledge Database Interrogation & Third-Layer Conclusions - COMPLETED
- **File**: `09_LITERATURE.md`
- **Duration**: 263s
- **Start**: 2026-10-22T01:30:03.520Z
- **End**: 2026-10-22T01:34:26.274Z
- **Token Usage**: Total: 800814, Prompt: 791559, Completion: 9255, Cached: 752257
- **Summary**:
Phase 9 complete. Confirmed prior websearch/knowledge/observations and read-only DuckDB (24 studies, 73 contexts, 1,149 assertions). Queried the documented seed/pathway strategy; returned MZB1 direct mention and 20 related assertions, with verbatim evidence quotes and study 10.1172/jci.insight.173273. The provided reverse-interrogation utility returned an empty contrast list despite the saved analysis catalog; documented this limitation and independently queried the exported unthresholded contrast with tidyproteomics annotation getters in lint-passing code/09_literature.R. Candidate results saved to data/literature_candidate_expression.csv and data/literature_candidate_fgsea.csv. Selected subthreshold trends include S100A9 (log2FC 0.816, p=6.14e-4) and LTA4H (0.697, p=0.015); custom candidate-set fgsea NES=1.544, p=0.0174, with a substantial tied-rank warning. Authored docs/literature.md with evidence subgraph, reverse-interrogation, contextual synthesis, hypothesis reconciliation, and documented references. Linter passed, targeted R query completed, logs/09_literature/console.log is nonempty, and checkpoint gate verified all required inputs/report/output artifacts. All interpretations retain the major caveat that condition and batch are associated and independent biological-subject mapping is unverified.

---

### Phase 10: Publication-Grade Scientific Manuscript Synthesis - COMPLETED
- **File**: `10_SYNTHESIS.md`
- **Duration**: 239s
- **Start**: 2026-10-22T01:34:26.282Z
- **End**: 2026-10-22T01:38:25.392Z
- **Token Usage**: Total: 521624, Prompt: 510370, Completion: 11254, Cached: 475157
- **Summary**:
Authored the publication-style integrated manuscript at docs/scientific_report.md, including abstract, methods, verified protein and enrichment result tables, three-layer biologically cautious discussion, cited literature evidence, conclusions, and dynamically verified links to existing code, logs, reports, data tables, and figures. The report foregrounds the batch/condition association and unknown subject independence as critical limits. Validation confirmed all required sections, core prerequisite reports/object/tables, and local artifact links; checkpoint gate passed for the report, prerequisite docs, RDS, quantitative tables, key figures, and all phase console logs.

---

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 22:18
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 22:26
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 22:33
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 22:48
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 22:49
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 

### Phase 5: Functional Annotation Assessment & Pathway Enrichment - COMPLETED

- **Run timestamp**: 2026-10-21 22:57
- **Annotation categories considered**: pathway, gene_ontology_biological_process, gene_ontology_cellular_component, gene_ontology_molecular_function, subcellular_location_cc, reactome, uni_pathway, pathway_commons
- **Enrichment status**: enrichment results audited and exported
- **Contrast(s)**: active_necrotic_granuloma/healthy
- **Interpretive limitation**: Any enrichment results inherit the exploratory expression analysis limitations: disease group and acquisition batch are associated, and independent subject mapping is unverified. Results are descriptive and do not establish disease-specific effects.
- **Persistence**: Enriched or preserved object saved to `data/tidyproteomics_data.rds`; tidyproteomics v1.9.15.
- **Provenance**: `docs/llm.md`; script: `code/05_enrichment.R`; log: `logs/05_enrichment/console.log`. 
